Mesoporous silica nanoparticles as a compound delivery system in zebrafish embryos

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 1875-1890

  Sharif, Faiza ^a   Porta, Fabiola ^b   Meijer, Annemarie H ^c   Kros, Alexander ^b   Richardson, Michael K ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Immune cells; L plastin; Lysozyme; Mesoporous silica nanoparticles; Toxicity; TRAcP

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; BUFFER; COLONY STIMULATING FACTOR 1; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; MESOPOROUS SILICA NANOPARTICLE; NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EMBRYO; ANIMAL EXPERIMENT; ARTICLE; BONE REMODELING; CELL ACTIVATION; CELL DEATH; CELL INFILTRATION; CELLULAR IMMUNITY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; EMBRYO; EMBRYO DEVELOPMENT; IN VIVO STUDY; NANOANALYSIS; NANOCHEMISTRY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PARTICLE SIZE; PROTEIN FUNCTION; TOXICITY TESTING; TRANSGENIC ANIMAL; UPREGULATION; ZEBRA FISH;

ACID PHOSPHATASE; ANIMALS; ANIMALS, GENETICALLY MODIFIED; APOPTOSIS; DRUG CARRIERS; EMBRYO, NONMAMMALIAN; FEMALE; HISTOCYTOCHEMISTRY; ISOENZYMES; MALE; MEMBRANE GLYCOPROTEINS; MICROFILAMENT PROTEINS; NANOPARTICLES; NEUTROPHIL INFILTRATION; SILICON DIOXIDE; TISSUE DISTRIBUTION; ZEBRAFISH;

DANIO RERIO;

EID: 84870371389     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S26547     Document Type: Article

References (46)

1. Singh S, Nalwa HS. Nanotechnology and health safety-toxicity and risk assessments of nanostructured materials on human health. J Nanosci Nanotechnol. 2007;7:3048-3070.
2. Medintz IL, Uyeda HT, Goldman ER, Mattoussi H. Quantum dot bioconjugates for imaging, labelling and sensing. Nat Mater. 2005;4: 435-446.
3. Caruthers SD, Wickline SA, Lanza GM. Nanotechnological applications in medicine. Curr Opin Biotechnol. 2007;18:26-30.
4. Dobrovolskaia MA, McNeil SE. Immunological properties of engineered nanomaterials. Nat Nanotechnol. 2007;2:469-478.
5. Duncan R, Izzo L. Dendrimer biocompatibility and toxicity. Adv Drug Deliv Rev. 2005;57:2215-2237.
6. Oberdorster G, Oberdorster E, Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect. 2005;113:823-839.
7. Smart SK, Cassady AI, Lu GQ, Martin DJ. The biocompatibility of carbon nanotubes. Carbon. 2006;44:1034-1047.
8. Hardonk MJ, Harms G, Koudstaal J. Zonal heterogeneity of rat hepatocytes in the in vivo uptake of 17 nm colloidal gold granules. Histochemistry. 1985;83:473-477.
9. Nakamura E, Isobe H. Functionalized fullerenes in water. The first 10 years of their chemistry, biology, and nanoscience. Acc Chem Res. 2003;36:807-815.
10. Slowing I, Trewyn BG, Lin VS. Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells. J Am Chem Soc. 2006;128: 14792-14793.
11. Slowing II, Trewyn BG, Lin VSY. Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins. J Am Chem Soc. 2007;129:8845-8849.
12. Lu J, Liong M, Zink J, Tamanoi F. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. Small. 2007;3:1341-1346.
13. Lai CY, Trewyn BG, Jeftinija DM, et al. A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. J Am Chem Soc. 2003;125: 4451-4459.
14. Rejman J, Oberle V, Zuhorn IS, Hoekstra D. Size-dependent internalization of particles via the pathways of clathrin-and caveolae-mediated endocytosis. Biochem J. 2004;377: 159-169.
15. Griffitt RJ, Luo J, Gao J, Bonzongo JC, Barber DS. Effects of particle composition and species on toxicity of metallic nanomaterials in aquatic organisms. Environ Toxicol Chem. 2008;27:1972-1978.
16. Klaine SJ, Alvarez PJ, Batley GE, et al. Nanomaterials in the environment: behavior, fate, bioavailability, and effects. Environ Toxicol Chem. 2008;27:1825-1851.
17. Oberdorster E. Manufactured nanomaterials (fullerenes, C60) induce oxidative stress in the brain of juvenile largemouth bass. Environ Health Perspect. 2004;112:1058-1062.
18. Kashiwada S. Distribution of nanoparticles in the see-through medaka Oryzias latipes. Environ Health Perspect. 2006;114:1697-1702.
19. Brunner TJ, Wick P, Manser P, et al. In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. Environ Sci Technol. 2006;40:4374-4381.
20. Fent K, Weisbrod CJ, Wirth-Heller A, Pieles U. Assessment of uptake and toxicity of fluorescent silica nanoparticles in zebrafish (Danio rerio) early life stages. Aquat Toxicol. 2010;100:218-228.
21. Akerman ME, Chan WC, Laakkonen P, Bhatia SN, Ruoslahti E. Nanocrystal targeting in vivo. Proc Natl Acad Sci U S A. 2002;99: 12617-12621.
22. Paciotti GF, Myer L, Weinreich D, et al. Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv. 2004;11:169-183.
23. Mathias JR, Dodd ME, Walters KB, Yoo SK, Ranheim EA, Huttenlocher A. Characterization of zebrafish larval inflammatory macrophages. Dev Comp Immunol. 2009;33:1212-1217.
24. Mathias JR, Perrin BJ, Liu TX, Kanki J, Look AT, Huttenlocher A. Resolution of inflammation by retrograde chemotaxis of neutrophils in transgenic zebrafish. J Leukoc Biol. 2006;80:1281-1288.
25. Hall C, Flores MV, Storm T, Crosier K, Crosier P. The zebrafish lysozyme C promoter drives myeloid-specific expression in transgenic fish. BMC Dev Biol. 2007;7:42.
26. Meijer AH, van der Sar AM, Cunha C, et al. Identification and realtime imaging of a myc-expressing neutrophil population involved in inflammation and mycobacterial granuloma formation in zebrafish. Dev Comp Immunol. 2008;32:36-49.
27. Dahm R, Geisler R. Learning from small fry: the zebrafish as a genetic model organism for aquaculture fish species. Mar Biotechnol NY. 2006;8:329-345.
28. Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF. Stages of embryonic development of the zebrafish. Dev Dyn. 1995;203:253-310.
29. de VE, Sharif F, Metz JR, Flik G, Richardson MK. Matrix metalloproteinases in osteoclasts of ontogenetic and regenerating zebrafish scales. Bone. 2011;48:704-712.
30. Spoorendonk KM, Hammond CL, Huitema LFA, Vanoevelen J, Schulte-Merker S. Zebrafish as a unique model system in bone research: the power of genetics and in vivo imaging. J Appl Ichthyol. 2010;26:219-224.
31. Flores MV, Lam EY, Crosier P, Crosier K. A hierarchy of Runx transcription factors modulate the onset of chondrogenesis in craniofacial endochondral bones in zebrafish. Dev Dyn. 2006;235: 3166-3176.
32. Yan YL, Willoughby J, Liu D, et al. A pair of Sox: distinct and overlapping functions of zebrafish sox9 co-orthologs in craniofacial and pectoral fin development. Development. 2005;132:1069-1083.
33. Li N, Felber K, Elks P, Croucher P, Roehl HH. Tracking gene expression during zebrafish osteoblast differentiation. Dev Dyn. 2009;238:459-466.
34. Udagawa N, Takahashi N, Akatsu T, et al. Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrowderived stromal cells. Proc Natl Acad Sci U S A. 1990;87:7260-7264.
35. Collin-Osdoby P, Yu X, Zheng H, Osdoby P. RANKL-mediated osteoclast formation from murine RAW 264.7 cells. Methods Mol Med. 2003;80:153-166.
36. Ogris M, Brunner S, Schuller S, Kircheis R, Wagner E. PEGylated DNA/ transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther. 1999;6:595-605.
37. Gref R, Luck M, Quellec P, et al. 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol PEG.): influences of the corona PEG chain length and surface density and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf B Biointerfaces. 2000;18:301-313.
38. Ellett F, Pase L, Hayman JW, Andrianopoulos A, Lieschke GJ. mpeg1 promoter transgenes direct macrophage-lineage expression in zebrafish. Blood. 2011;117:e49-e56.
39. Cui C, Benard EL, Kanwal Z, et al. Infectious disease modeling and innate immune function in zebrafish embryos. Methods Cell Biol. In press.
40. Mathias JR, Perrin BJ, Liu TX, Kanki J, Look AT, Huttenlocher A. Resolution of inflammation by retrograde chemotaxis of neutrophils in transgenic zebrafish. J Leukoc Biol. 2006;80(6):1281-1288.
41. Wang S, Lu W, Tovmachenko O, Rai US, Yu H, Ray PC. Challenge in understanding size and shape dependent toxicity of gold nanomaterials in human skin keratinocytes. Chemical Physics Letters. 2008;463:145-149.
42. Wark M, Ortlam A, Ganschow M, Schulz-Ekloff G, Wöhrle D. Monomeric encapsulation of phthalocyanine-dye molecules in the pores of Si-MCM-41 and Ti-MCM-41. Berichte der Bunsengesellschaft für physikalische Chemie. 1998;102:1548-1553.
43. Fischer HC, Chan WC. Nanotoxicity: the growing need for in vivo study. Curr Opin Biotechnol. 2007;18:565-571.
44. Saba TM. Physiology and physiopathology of the reticuloendothelial system. Arch Intern Med. 1970;126:1031-1052.
45. Yamago S, Tokuyama H, Nakamura E, et al. In vivo biological behavior of a water-miscible fullerene: 14C labeling, absorption, distribution, excretion and acute toxicity. Chem Biol. 1995;2:385-389.
46. Lorenzo J. Characterization of osteoclast precursor cells in murine bone marrow. J Musculoskelet Neuronal Interact. 2003;3:273-277.